WEX Pharmaceuticals Inc. ("WEX" or the "Company") (TSX:WXI) today announced that the Toronto Stock Exchange (the "TSX") has conditionally approved certain amendments to the exercise prices and terms of 1,877,999 stock options (the "Prior Options") that were previously granted to certain directors, employees and consultants who are non-insiders of the Company. These amendments to the Prior Options are intended to coincide with the Company's planned rights offering to its existing shareholders (the "Rights Offering") and will only be effective if the Rights Offering proceeds.
